NeuroBo Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following press release that they use animals for product testing.
“NeuroBo’s IND-ready second drug candidate, NB-02, is targeted for the treatment of Alzheimer’s disease and neurodegenerative diseases associated with the pathological dysfunction of tau proteins in the brain. Preclinical animal disease model studies of NB-02 have provided evidence of efficacy and safety in neurodegeneration.” Read the following article
Company Website: https://www.neurobopharma.com